BTSG · Insider Trading
BrightSpring Health Services, Inc. Common Stock
Every open-market purchase and sale reported by BTSG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-27 | Jon B Rousseau | See Remarks | F | −36,355 | −$2.19M |
| 2026-09-16 | Scott A. Greenwell | President, PharMerica | MIXED | −3,126 | −$607.74K |
| 2026-07-28 | Jon B Rousseau | See Remarks | F | −56,319 | −$4.11M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Jon B Rousseau | See Remarks | 1,471,592 | $98.43M |
| Scott A. Greenwell | President, PharMerica | 46,345 | $3.10M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the BTSG quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.